ArticleCardiovascular toxicology2025

ELABELA-32 Alleviates Doxorubicin-Induced Chronic Cardiotoxicity by Inhibiting the TGF-β/Smad Signaling Pathway.

Shuang Zhou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.